STUNTING AND DEVELOPMENTAL DELAYS AMONG CHILDREN AGED 6–59 MO

Authors

  • HARDYA GUSTADA HIKMAHRACHIM Department of Epidemiology, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia
  • SUDARTO RONOATMODJO Department of Epidemiology, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia

DOI:

https://doi.org/10.22159/ijap.2020.v12s3.39477

Keywords:

Developmental delay, Primary healthcare facilities, Stunting

Abstract

Objective: This study aimed to investigate the association between stunting and suspected developmental delay status in Kabupaten Bogor.

Methods: An observational cross-sectional study was conducted in Puskesmas Kecamatan Ciampea, Kabupaten Bogor, Indonesia, from February to April 2019. We included children aged 6–59 mo who visited outpatient clinics. All eligible children underwent standardized anthropometric examinations and developmental milestone assessments using the Denver II tool. Both bivariate and multivariate analyses were conducted to investigate any associations.

Results: From 184 children, 76 (41.3%) were stunted and 82 (44.57%) had suspected developmental delays, both relatively higher than the national prevalence. Overall, developmental delays were associated with stunting (64.5% vs. 30.6%; adjusted odds ratio (AOR): 3.45; 95% CI: 1.76–6.76; p = 0.000). In subgroup analyses, stunting was independently associated with suspected delays in fine motor skills (26.3% vs. 12.9%; AOR: 2.49; 95% CI: 1.00–6.18; p = 0.049), personal‑social development (35.5% vs. 12.0%; AOR: 2.75; 95% CI: 1.24–6.12; p = 0.013) and language skills (27.6% vs. 12.9%; AOR: 2.95; 95% CI: 1.28–6.77; p = 0.011) after multivariate analyses with sex, age and undernutrition as confounding factors in the final model.

Conclusion: Stunting had a strong association with developmental delays among children visiting primary healthcare clinics. Stakeholders should focus on both the detection and prevention of stunting and developmental delays in primary healthcare facilities.

Downloads

Download data is not yet available.

References

Crane RJ, Berkley JA. Progress on growth faltering. Lancet Global Health 2017;5:e125-e6.

Bhutta ZA. Global child nutrition and the sustainable development goals. Lancet Child Adolescent Health 2017;1:256-7.

World Bank. Joint Child Malnutrition Estimates. UNICEF/WHO/World Bank May edition; 2018.

Kementerian Kesehatan Republik Indonesia. Hasil Utama Riskesdas. Jakarta: Kementerian Kesehatan Republik Indonesia; 2018.

Grantham McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B, et al. Developmental potential in the first 5 y for children in developing countries. Lancet 2007;369:60-70.

Hizni A, Julia M, Gamayanti IL. Status stunted dan hubungannya dengan perkembangan anak balita di wilayah pesisir pantai utara kecamatan lemahwungkuk kota cirebon. J Gizi Klinik Indonesia 2010;6:7.

Sitaresmi MN, Ismail D, Wahab A. Risk factors of developmental delay: a community-based study. Paediatr Indones 2008;43:161-6.

Miller AC, Murray MB, Thomson DR, Arbour MC. How consistent are associations between stunting and child development? Evidence from a meta-analysis of associations between stunting and multidimensional child development in fifteen low-and middle-income countries. Public Health Nutr 2016;19:1339-47.

Engle PL, Black MM, Behrman JR, Cabral de Mello M, Gertler PJ, Kapiriri L, et al. Strategies to avoid the loss of developmental potential in more than 200 million children in the developing world. Lancet 2007;369:229-42.

Hall C, Bennett C, Crookston B, Dearden K, Hasan M, Linehan M, et al. Maternal knowledge of stunting in rural Indonesia. Int J Child Health Nutr 2018;7:139-45.

Budge S, Parker AH, Hutchings PT, Garbutt C. Environmental enteric dysfunction and child stunting. Nutr Rev 2019;77:240-53.

Bourke CD, Jones KDJ, Prendergast AJ. Current understanding of innate immune cell dysfunction in childhood undernutrition. Front Immunol 2019;10:1728.

Harper KM, Mutasa M, Prendergast AJ, Humphrey J, Manges AR. Environmental enteric dysfunction pathways and child stunting: a systematic review. PLoS Negl Trop Dis 2018;12:e0006205.

Lukman F, Sri Rattana R, Lindra A, Nimas Dwi Ayu R. editors. Empowerment of trained health volunteers to increase detection rate of children with developmental delay in urban Kendal, Indonesia. International Seminar Public Health Education; 2018.

Febrikaharisma MH. Hubungan antara TB/U dengan fungsi motorik anak usia 2-4 tahun. Semarang: Universitas Diponegoro; 2013.

Hanani R, Syauqi A. Perbedaan perkembangan motorik kasar, motorik halus, bahasa, dan personal sosial pada anak stunting dan non stunting. Semarang: Universitas Diponegoro; 2016.

Ozkan M, Senel S, Arslan EA, Karacan CD. The socioeconomic and biological risk factors for developmental delay in early childhood. Eur J Pediatr 2012;171:1815-21.

Widyastuti SB, Soedjatmiko, Firmansyah A. Growth and development profile of children at two day care centers in Jakarta. Paediatr Indones 2005;45:275-80.

Walker SP, Wachs TD, Gardner JM, Lozoff B, Wasserman GA, Pollitt E, et al. Child development: risk factors for adverse outcomes in developing countries. Lancet 2007;369:145-57.

Benjamin TE, Lucas Thompson RG, Little LM, Davies PL, Khetani MA. Participation in early childhood educational environments for young children with and without developmental disabilities and delays: a mixed methods study. Phys Occup Ther Pediatr 2017;37:87-107.

Lehr M, Wecksell B, Nahum L, Neuhaus D, Teel KS, Linares LO, et al. Parenting stress, child characteristics, and developmental delay from birth to age five in teen mother–child dyads. J Child Family Studies 2016;25:1035-43.

Gould JF. Complementary feeding, micronutrients and developmental outcomes of children. Nestle Nutr Inst Workshop Ser 2017;87:13-28.

Suryaputri IY, Rosha B, Anggraeni D. Determinan kemampuan motorik anak berusia 2-5 tahun: studi kasus di kelurahan kebon kalapa bogor. Penel Gizi Makan 2014;37:43-50.

Published

15-10-2020

How to Cite

HIKMAHRACHIM, H. G., & RONOATMODJO, S. (2020). STUNTING AND DEVELOPMENTAL DELAYS AMONG CHILDREN AGED 6–59 MO. International Journal of Applied Pharmaceutics, 12(3), 67–71. https://doi.org/10.22159/ijap.2020.v12s3.39477

Issue

Section

Full Proceeding Paper